The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review
Open accessAbstract
Frontotemporal dementia (FTD) is the second most common young-onset dementia and is clinically characterised by progressive behavioural change, executive dysfunction and language difficulties. Three clinical syndromes, behavioural variant FTD, semantic dementia and progressive non-fluent aphasia, form part of a clinicopathological spectrum named frontotemporal lobar degeneration (FTLD). The classical neuropsychological phenotype of FTD has been enriched by tests exploring Theory of Mind, social cognition and emotional processing. Imaging studies have detailed the patterns of atrophy associated with different clinical and pathological subtypes. These patterns offer some diagnostic utility, while measures of progression of atrophy may be of use in future trials. 30-50% of FTD is familial, and mutations in two genes, microtubule associated protein tau and Progranulin (GRN), account for about half of these cases. Rare defects in VCP, CHMP2B, TARDP and FUS genes have been found in a small number of families. Linkage to chromosome 9p13.2-21.3 has been established in familial FTD with motor neuron disease, although the causative gene is yet to be identified. Recent developments in the immunohistochemistry of FTLD, and also in amyotrophic lateral sclerosis (ALS), have led to a new pathological nomenclature. The two major groups are those with tau-positive inclusions (FTLD-tau) and those with ubiquitin-positive and TAR DNA-binding protein of 43 kDa (TDP-43) positive inclusions (FTLD-TDP). Recently, a new protein involved in familial ALS, fused in sarcoma (FUS), has been found in FTLD patients with ubiquitin-positive and TDP-43-negative inclusions. In this review, the authors discuss recent clinical, neuropsychological, imaging, genetic and pathological developments that have changed our understanding of FTD, its classification and criteria. The potential to establish an early diagnosis, predict underlying pathology during life and quantify disease progression will all be required for disease-specific therapeutic trials in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These brain regions have been previously shown to be susceptible to age-related neurodegenerative diseases.”
From Molecular and spatial signatures of mouse brain aging at single-cell resolution (2023) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, there are several different pathological proteins and aggregation morphologies in FTD, with generally weak correlations between clinical syndrome and the type of pathological protein (Seelaar et al., 2011)”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Seelaar et al., 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, there are several different pathological proteins and aggregation morphologies in FTD, with generally weak correlations between clinical syndrome and the type of pathological protein (Seelaar et al., 2011)”
From Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum (2020) · cites this paper as Seelaar et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–222 of 222
Rohrer, J. D., Warren, J. D., Omar, R., Mead, S., Beck, J. A., Révész, T., Holton, J. L., Stevens, J., Al‐Sarraj, S., Pickering-Brown, S. M., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.506 · Cited by 54
Self-citationBehavioural variant Frontotemporal Dementia: Not all it seems?
Kipps, C., Nestor, P. J., Fryer, T. D., & Hodges, J. R. (2007) · Neurocase · doi:10.1080/13554790701594870 · Cited by 53
Frontotemporal lobar degeneration with ubiquitin-positive, but TDP-43-negative inclusions
Josephs, K. A., Lin, W.-L., Ahmed, Z., Stroh, D. A., Graff‐Radford, N. R., & Dickson, D. W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0397-8 · Cited by 53
Frequency of Dementia Etiologies in Four Ethnic Groups
Hou, C. E., Yaffe, K. S., Pérez‐Stable, E. J., & Miller, B. L. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000093217 · Cited by 53
Cortical Atrophy and Language Network Reorganization Associated with a Novel Progranulin Mutation
Cruchaga, C., Fernández‐Seara, M. A., Seijo‐Martínez, M., Samaranch, L., Lorenzo, E., Hinrichs, A. L., Irigoyen, J., Maestro, C., Prieto, E., Martí-Climent, J. M., et al. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn202 · Cited by 51
Mapping the progression of progranulin-associated frontotemporal lobar degeneration
Rohrer, J. D., Warren, J. D., Barnes, J., Mead, S., Beck, J. A., Pepple, T., Boyes, R. G., Omar, R., Collinge, J., Stevens, J., et al. (2008) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0869 · Cited by 50
Self-citationNo association of PGRN 3′UTR rs5848 in frontotemporal lobar degeneration
Rollinson, S. J., Rohrer, J. D., van der Zee, J., Sleegers, K., Mead, S., Engelborghs, S., Collinge, J., Deyn, P. P. D., Mann, D. M. A., Broeckhoven, C. V., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.04.009 · Cited by 48
Self-citationUbiquitin associated protein 1 is a risk factor for frontotemporal lobar degeneration
Rollinson, S. J., Rizzu, P., Sikkink, S. K., Baker, M., Halliwell, N. A., Snowden, J. S., Traynor, B. J., Ruano, D., Cairns, N. J., Rohrer, J. D., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.009 · Cited by 41
Self-citationSrinivasan, R. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.063966 · Cited by 39
The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration
Rohrer, J. D., Lashley, T., Holton, J. L., Révész, T., Urwin, H., Isaacs, A. M., Fox, N. C., Rossor, M. N., & Warren, J. D. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.214437 · Cited by 39
Self-citationAdditional Value of CSF Amyloid-β40 Levels in the Differentiation between FTLD and Control Subjects
Verwey, N. A., Kester, M. I., van der Flier, W. M., Veerhuis, R., Berkhof, J. H., Twaalfhoven, H. A. M., Blankenstein, M. A., Scheltens, P., & Pijnenburg, Y. A. L. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1392 · Cited by 34
Self-citationALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
Parkinson, N. (2006) · Neurology · doi:10.1212/01.wnl.0000236199.11821.85 · Cited by 33
The Scale for Emotional Blunting in Patients with Frontotemporal Dementia
Mendez, M. F., McMurtray, A. M., Licht, E. A., Shapira, J. S., Saul, R. E., & Miller, B. L. (2006) · Neurocase · doi:10.1080/13554790600910375 · Cited by 31
Marra, C., Quaranta, D., Zinno, M., Misciagna, S., Bizzarro, A., Masullo, C., Daniele, A., & Gainotti, G. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000108115 · Cited by 31
Simón‐Sánchez, J., Seelaar, H., Bochdanovits, Z., Deeg, D. J. H., Swieten, J. C. V., & Heutink, P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007494 · Cited by 28
Self-citationCLINICAL SYNDROMES ASSOCIATED WITH POSTERIOR ATROPHY: EARLY AGE AT ONSET AD SPECTRUM
Ridgway, G. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e794d5 · Cited by 15
The CST3 B haplotype is associated with frontotemporal lobar degeneration
Benussi, L., Ghidoni, R., Galimberti, D., Boccardi, M., Fenoglio, C., Scarpini, E. A., Frisoni, G. B., & Binetti, G. G. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02767.x · Cited by 14
Prion protein (PRNP) genotypes in frontotemporal lobar degeneration syndromes
Rohrer, J. D., Mead, S., Omar, R., Poulter, M., Warren, J. D., Collinge, J., & Rossor, M. N. (2006) · Annals of Neurology · doi:10.1002/ana.20931 · Cited by 13
Self-citationProgranulin Mutations in Primary Progressive Aphasia: The PPA1 and PPA3 Families
Verma, A. (2008) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)79012-4 · Cited by 11
Emotion, social functioning and activities of daily living in frontotemporal dementia
Kipps, C., Mioshi, E., & Hodges, J. R. (2020) · Neurocase · doi:10.4324/9781003059790-2 · Cited by 6
Executive dysfunction in frontotemporal dementia and corticobasal syndrome
(2010) · Neurology · doi:10.1212/wnl.0b013e3181f98108 · Cited by 5
Refining Frontotemporal Dementia With Parkinsonism Linked to Chromosome 17
Boeve, B. F., & Hutton, M. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.460
Research works printed but not linked: 2
- Pick A. U ¨ber die Beziehungen der senilen Hirnatropie zur Aphasie. Pragen Medizinischen Wochenschrift 1892;17:165e7.
- Alzheimer A. U ¨ber eigenartige Krankheitsfa ¨lle des spa ¨teren Alters. Zbl Ges Neurol Psych 1911;4:356e85.
Cited by
Sorted by citations
Qualitative Assessment of Verbal Fluency Performance in Frontotemporal Dementia
van den Berg, E., Jiskoot, L. C., Grosveld, M. J. H., Swieten, J. C. V., & Papma, J. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477538 · Cited by 2,065
Considering sex and gender in Alzheimer disease and other dementias
Podcasy, J., & Epperson, C. N. (2016) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2016.18.4/cepperson · Cited by 727
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
Self-citationTau imaging: early progress and future directions
Villemagne, V. L., Fodero-Tavoletti, M. T., Masters, C. L., & Rowe, C. C. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70252-2 · Cited by 501
Enhanced Protein Degradation by Branched Ubiquitin Chains
Meyer, H., & Rapé, M. (2014) · Cell · doi:10.1016/j.cell.2014.03.037 · Cited by 493
Metadata
- Authors
- Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A. L., Fox, N. C., & van Swieten, J. C.
- Affiliations
- Erasmus MC (NL)
- National Hospital for Neurology and Neurosurgery (GB)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2010-10-22
- Volume
- 82
- Issue
- 5
- Pages
- 476-486
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2102932082
- Cited by
- 609
- References
- 222
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 39 · 2023: 23 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 42 · 2018: 34 · 2017: 31 · 2016: 49 · 2015: 41 · 2014: 45 · 2013: 65 · 2012: 54
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurology Neurosurgery & Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion, other-oa)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Alzheimer's Research Trust
- National Institute for Health and Care Research (NF-SI-0508-10123)
- Hersenstichting
- Stichting Dioraphte
- Medical Research Council
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- frontotemporal dementia, frontotemporal lobar degeneration, semantic dementia, progressive nonfluent aphasia, tauopathy, TDP-43, FUS, progranulin, tau protein, VCP, CHMP2B, amyotrophic lateral sclerosis, neuroimaging, brain atrophy, neuropsychological assessment, disease progression, early diagnosis, genetic heterogeneity
- MeSH terms
- Progranulins, Brain, Cognition, Humans, Magnetic Resonance Imaging, Risk Factors, Social Perception, Biomarkers, tau Proteins, Intercellular Signaling Peptides and Proteins, Executive Function, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
